Skip to content
Home/Companies/Healthcare/Reaction Biology
Reaction Biology

Reaction Biology

Healthcare·US·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Reaction Biology?

Reaction Biology is currently owned by Cobepa through Cobepa (2004 vintage), since 2022.

Hand-verified · updated 2026-06-30

Cobepa
Investor
Cobepa
Cobepa · 2004 · Evergreen

Key facts

HQUnited States
SectorHealthcare
StatusActive
Websitewww.reactionbiology.com

More from Cobepa

Other portfolio companies in the same fund.

Prosol
Active
ConsumerFrance· 2026
Eagle Fire
Eagle Fire
Active
Business ServicesUS· 2025
Itineris
Itineris
Active
SoftwareBelgium· 2025
SAX
SAX
Active
Business ServicesUS· 2025
Ascentiel
Active
TMTFrance· 2024
Ascentiel Groupe
Ascentiel Groupe
Active
FinancialsFrance· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Reaction Biology

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Reaction Biology?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Reaction Biology.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue